The temporary pacemaker is used with a cardiac pacing lead system for temporary single or dual chamber pacing in a clinical environment by trained personnel. The temporary pacemaker can be used where short-term demand (synchronous) or asynchronous pacing is indicated for therapeutic, prophylactic or diagnostic purposes. The temporary pacemaker must be used in an environment where the patient is monitored continuously to ensure that it is operating properly and delivering appropriate therapy to the patient.

Specific indications for temporary cardiac pacing include, but are not limited to, the following:

Complete heart block
Sinus bradycardia
Sick sinus syndrome
Bradycardia with congestive heart failure
Atrial and/or ventricular arrhythmias
Cardiac arrest
Support, management, and evaluation of a patient prior to permanent pacemaker Implantation
Support during permanent pacemaker replacement
Cardiac complications during invasive or surgical procedures
Support following cardiac surgery
Acute myocardial infarction complicated by heart block
Atrial tachyarrhythmias that require high-rate burst pacing for treatment

Device Description

The Model 5392 EPG is a battery-powered, dual chamber, temporary pacemaker designed primarily for temporary antibradycardia pacing therapy. The 53922 EPG cover accessory is an optional disposable protective cover to reduce accidental activation of the controls of the 5392 EPG.

AI/ML Overview

This FDA 510(k) premarket notification is for a Medtronic Model 5392 External Pulse Generator (EPG). This document establishes substantial equivalence to a previously cleared device, rather than proving performance against specific acceptance criteria in a clinical study for a new device. Therefore, many of the requested categories for a new device's performance study are not directly applicable or are not detailed in this document.

The core of this submission is to demonstrate that the modified Medtronic Model 5392 EPG is substantially equivalent to its predicate device (Medtronic Model 5392 EPG K132924), despite a minor design modification.

Here's the information presented, framed within your requested categories:

1. Table of Acceptance Criteria and Reported Device Performance

Acceptance Criteria Category	Acceptance Criteria (Implied)	Reported Device Performance
Intended Use/Indications for Use	Same as predicate device	Same as predicate device
Operating Principle	Same as predicate device	Same as predicate device
Design Features	Largely same as predicate device	Largely same as predicate device (with one stated modification)
Device Functionality	Same as predicate device	Same as predicate device
Biological Safety	Same as predicate device	Same as predicate device
Packaging Materials	Same as predicate device	Same as predicate device
Shelf Life	Same as predicate device	Same as predicate device
Safety and Effectiveness	No new safety or performance issues introduced by modification, meeting product-level performance requirements.	"The results of the above [bench] verification tests met the specified acceptance criteria and did not raise new safety or performance issues."

Explanation: The "acceptance criteria" here are primarily based on demonstrating that the modified device performs equivalently to the predicate device, especially considering the minor "modified negative battery contact design." Performance is implicitly accepted if it aligns with the predicate and passes standard engineering verification.

2. Sample Size Used for the Test Set and the Data Provenance

This document describes bench testing for verification, not clinical studies with human participants. Therefore:

Sample Size: Not explicitly stated in terms of patient numbers or clinical test cases. The testing was "regression bench testing to product level performance requirements." This implies engineering test units.
Data Provenance: Not applicable. This refers to engineering bench test data, not patient data.

3. Number of Experts Used to Establish the Ground Truth for the Test Set and the Qualifications of Those Experts

Not applicable. Ground truth for clinical outcomes or diagnoses is not established in this type of submission focused on substantial equivalence through bench testing. The "truth" is whether the device meets its engineered specifications and performs consistently with the predicate.

4. Adjudication Method for the Test Set

Not applicable. Adjudication methods (like 2+1, 3+1) are used for clinical studies to resolve discrepancies among human readers/experts. This submission focuses on engineering verification.

5. If a Multi Reader Multi Case (MRMC) Comparative Effectiveness Study Was Done, If So, What Was the Effect Size of How Much Human Readers Improve with AI vs Without AI Assistance

Not applicable. This is a medical device for providing temporary cardiac pacing, not an AI-powered diagnostic or assistive tool for human readers.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

Not applicable. This device is an external pulse generator, not an algorithm. Its operation inherently involves "trained personnel" in a "clinical environment where the patient is monitored continuously."

7. The Type of Ground Truth Used

The "ground truth" for this substantial equivalence submission is based on engineering specifications and performance characteristics of the predicate device, as confirmed through bench testing. It's about demonstrating that the modified device's performance aligns with established engineering standards and the known performance of the predicate, not clinical outcomes derived from expert consensus, pathology, or long-term patient follow-up.

8. The Sample Size for the Training Set

Not applicable. There is no mention of a training set for an algorithm, as this is a hardware device.

9. How the Ground Truth for the Training Set Was Established

Not applicable, as there is no training set for an algorithm described in this document.

Summary

{0}------------------------------------------------

Public Health Service

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

February 19, 2015

Medtronic, Inc. c/o Becky Severson Sr. Regulatory Associate 8200 Coral Sea Street NE Mounds View, Minnesota 55112

Re: K150246

Trade/Device Name: Medtronic Model 5392 External Pulse Generator (EPG) Regulation Number: 21 CFR 870.3600 Regulation Name: External Pacemaker Pulse Generator Regulatory Class: Class III Product Code: DTE Dated: January 30, 2015 Received: February 2, 2015

Dear Becky Severson,

This letter corrects our substantially equivalent letter of February 18, 2015.

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act

{1}------------------------------------------------

or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

M.A. Hillebrand

for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number: K150246

Device Name: Medtronic Model 5392 External Pulse Generator (EPG)

Indications for Use: The temporary pacemaker is used with a cardiac pacing lead system for temporary single or dual chamber pacing in a clinical environment by trained personnel. The temporary pacemaker can be used where short-term demand (synchronous) or asynchronous pacing is indicated for therapeutic, prophylactic or diagnostic purposes. The temporary pacemaker must be used in an environment where the patient is monitored continuously to ensure that it is operating properly and delivering appropriate therapy to the patient.

Specific indications for temporary cardiac pacing include, but are not limited to, the following:

Complete heart block ●
Sinus bradycardia ●
Sick sinus syndrome ●
Bradycardia with congestive heart failure ●
Atrial and/or ventricular arrhythmias
Cardiac arrest
Support, management, and evaluation of a patient prior to permanent pacemaker ● Implantation
Support during permanent pacemaker replacement ●
Cardiac complications during invasive or surgical procedures
Support following cardiac surgery ●
Acute myocardial infarction complicated by heart block ●
o Atrial tachyarrhythmias that require high-rate burst pacing for treatment

Prescription Use _ X__________AND/OR Over-The-Counter Use (Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

{3}------------------------------------------------

510(k) Summary 2

[As required by 21 CFR 807.92]

Date Prepared:	January 30, 2015
Submitter:	Medtronic, Inc.Medtronic Cardiac Rhythm Heart Failure8200 Coral Sea Street N.E.Mounds View, MN 55112Establishment Registration Number: 2182208
Contact Person:	Becky SeversonSenior Regulatory Affairs SpecialistMedtronic Cardiac Rhythm Heart FailurePhone: 763.526.2365Fax: 651.367.0603Email: becky.t.severson@medtronic.com
Alternate Contact:	Ryan CalabreseDirector Regulatory AffairsMedtronic Cardiac Rhythm Heart FailurePhone: 763.526.3515Fax: 651.367.0603Email: ryan.s.calabrese@medtronic.com

General Information

Trade Name:	Medtronic Model 5392 External Pulse Generator (EPG)
Common Name:	External pacemaker pulse generator
Regulation Number:	21 CFR 870.3600
Product Code:	DTE
Classification:	Class III
Classification Panel:	Cardiovascular
Special Controls:	Not applicable
Predicate Devices:	Medtronic Model 5392 External Pulse Generator (EPG) K13292-

{4}------------------------------------------------

Device Description

Indications for Use

Specific indications for temporary cardiac pacing include, but are not limited to, the following:

. Complete heart block
o Sinus bradycardia
Sick sinus syndrome ●
Bradycardia with congestive heart failure ●
Atrial and/or ventricular arrhythmias
Cardiac arrest ●
Support, management, and evaluation of a patient prior to permanent pacemaker Implantation
Support during permanent pacemaker replacement ●
Cardiac complications during invasive or surgical procedures ●
o Support following cardiac surgery
Acute myocardial infarction complicated by heart block ●
Atrial tachyarrhythmias that require high-rate burst pacing for treatment ●

Technological Characteristics

Intended use, design, materials, performance and technological characteristics are substantially equivalent to the predicate devices referenced.

Technological Characteristics

When compared to the predicate device (K132924), the modified Medtronic Model 5392 External Pulse Generator presented in this submission has the same:

Intended use/indications for use ●
Operating principle ●
Design features ●

{5}------------------------------------------------

Device functionality ●
o Biological safety
Packaging materials
Shelf life ●

The modified Model 5392 EPG and the predicate device differ in the following:

Modified negative battery contact design ●

Substantial Equivalence and Summary of Studies:

Technological differences between the subject and predicate devices have been evaluated through bench tests to provide evidence of safe and effective use. The modified Medtronic Model 5392 External Pulse Generator is substantially equivalent to the specified predicate device based on comparisons of the device functionality, technological characteristics, and indications for use. The device design and materials have been verified through the following:

Regression bench testing to product level performance requirements ●

Conclusion:

The results of the above verification tests met the specified acceptance criteria and did not raise new safety or performance issues. Therefore, the modifications made to the Medtronic Model 5392 External Pulse Generator described in this submission result in a device that is substantially equivalent to the predicate.

Regulation Number and Section

§ 870.3600 External pacemaker pulse generator.

(a)
Identification. An external pacemaker pulse generator (EPPG) is a prescription device that has a power supply and electronic circuits that produce a periodic electrical pulse to stimulate the heart. This device, which is used outside the body, is used as a temporary substitute for the heart's intrinsic pacing system until a permanent pacemaker can be implanted, or to control irregular heartbeats in patients following cardiac surgery or a myocardial infarction. The device may have adjustments for impulse strength, duration, R-wave sensitivity, and other pacing variables.(b)
Classification. Class II (special controls). The special controls for this device are:(1) Appropriate analysis/testing must validate electromagnetic compatibility (EMC) within a hospital environment.
(2) Electrical bench testing must demonstrate device safety during intended use. This must include testing with the specific power source (
i.e., battery power, AC mains connections, or both).(3) Non-clinical performance testing data must demonstrate the performance characteristics of the device. Testing must include the following:
(i) Testing must demonstrate the accuracy of monitoring functions, alarms, measurement features, therapeutic features, and all adjustable or programmable parameters as identified in labeling;
(ii) Mechanical bench testing of material strength must demonstrate that the device and connection cables will withstand forces or conditions encountered during use;
(iii) Simulated use analysis/testing must demonstrate adequate user interface for adjustable parameters, performance of alarms, display screens, interface with external devices (
e.g. data storage, printing), and indicator(s) functionality under intended use conditions; and(iv) Methods and instructions for cleaning the pulse generator and connection cables must be validated.
(4) Appropriate software verification, validation, and hazard analysis must be performed.
(5) Labeling must include the following:
(i) The labeling must clearly state that these devices are intended for use in a hospital environment and under the supervision of a clinician trained in their use;
(ii) Connector terminals should be clearly, unambiguously marked on the outside of the EPPG device. The markings should identify positive (+) and negative (−) polarities. Dual chamber devices should clearly identify atrial and ventricular terminals;
(iii) The labeling must list all pacing modes available in the device;
(iv) Labeling must include a detailed description of any special capabilities (
e.g., overdrive pacing or automatic mode switching); and(v) Appropriate electromagnetic compatibility information must be included.